Streetbeat News

Analyst Ratings

GOSS

Wedbush analyst Andreas Argyrides has reiterated an Outperform rating on Gossamer Bio (NASDAQ:GOSS) and maintained a $5 price target.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:40 pm

SGMO

Wedbush analyst Andreas Argyrides has maintained an 'Outperform' rating on Sangamo Therapeutics (NASDAQ:SGMO), but lowered the price target from $16 to $10.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:38 pm

VERA

Wedbush analyst Laura Chico maintains a Neutral rating on Vera Therapeutics (NASDAQ:VERA) and raises the price target from $12 to $16.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:37 pm

EWTX

Wedbush analyst Laura Chico has reiterated her 'Outperform' rating on Edgewise Therapeutics (NASDAQ:EWTX) and maintained a price target of $27.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:37 pm

OSS

One Stop Systems (OSS) reported lower than expected Q2 revenue and issued Q3 revenue guidance below estimates. This led to multiple firms downgrading the stock and lowering their price targets.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 2:37 pm

UMH

Wedbush analyst Henry Coffey maintains an Outperform rating on UMH Properties (NYSE:UMH) and raises the price target from $19 to $20.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:36 pm

PGY

Wedbush analyst David Chiaverini maintains a Neutral rating on Pagaya Techs (NASDAQ:PGY) and raises the price target from $1.5 to $3.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:35 pm

FDX

Stephens & Co. analyst Jack Atkins has reiterated an Overweight rating on FedEx (NYSE:FDX) and maintained a price target of $290.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:34 pm

UNH

Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on UnitedHealth Group (NYSE:UNH) and maintained a price target of $560.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:33 pm

FLO

Stephens & Co. analyst Tim Perz has reiterated an Equal-Weight rating on Flowers Foods (NYSE:FLO) and maintained a $25 price target.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 2:32 pm